Mutual funds are subject to market risk. Read all scheme documents carefully.
The fund is rated 5 stars. Taken together, the fund's movement relative to its index and annual fee of 1.08% place it ahead of most similar funds.
This index fund/ETF has a beta of 1.066%, and an expense ratio of 1.08%, giving it a 5.0 star rating, based on the principle that lower values of |1-beta| and expense ratio result in higher ratings.
Our score weighs long-term performance, risk and consistency — not just past returns.
As of 4 Nov 2026
As of 31 Oct 2026
Long-term capital growth. Investment in equity and equity related securities covered by Nifty Midcap 150 Quality 50 Index, subject to tracking error.
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Midcap 150 Quality 50 Index, subject to tracking error.
As of 30 Sep 2026
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| Dixon Technologies (India) Ltd. | 4.56% | ₹18.11 Cr | 13,827 |
| Colgate-Palmolive (India) Ltd. | 4.29% | ₹17.07 Cr | 96,828 |
| BSE Ltd. | 4.23% | ₹16.83 Cr | 54,429 |
| Hero Motocorp Ltd. | 3.90% | ₹15.49 Cr | 29,555 |
| Marico Ltd. | 3.60% | ₹14.33 Cr | 1,82,314 |
| Persistent Systems Ltd. | 3.44% | ₹13.7 Cr | 25,948 |
| Page Industries Ltd. | 2.90% | ₹11.55 Cr | 3,173 |
| Polycab India Ltd. | 2.61% | ₹10.39 Cr | 12,940 |
| Glaxosmithkline Pharmaceuticals Ltd. | 2.55% | ₹10.14 Cr | 36,626 |
| Oracle Financial Services Software Ltd. | 2.49% | ₹9.91 Cr | 9,327 |
